Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation

Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation

We have conducted a quantitative evaluation of ultrastructural changes in the dynamics of platelets in the patients with diabetes mellitus type 2 in a subcompensation phase with arterial hypertension under correction of arterial blood pres-sure with losartan and with considering of microalbuminuria....

Full description

Bibliographic Details
Main Author:	Pertseva N.O.
Format:	Article
Language:	Russian
Published:	Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy 2012-01-01
Series:	Морфологія
Subjects:	diabetes mellitus type 2 subcompensation arterial hypertension platelets ultrastructure losartan
Online Access:	http://www.morphology.dp.ua/_pub/MORPHO-2012-06-03/12pnotfs.pdf

Similar Items

Quantitative ultrastructural characteristics of platelets in the patients with diabetes mellitus type 2 in a compensation with arterial hypertension under correction of arterial blood pressure with losartan
by: Pertseva N.O.
Published: (2011-01-01)

Ultrastructural features of platelets in the patients with diabetes mellitus type 2 in a decompensation with arterial hypertension under correction of arterial blood pressure with losartan
by: Pertseva N.O.
Published: (2012-01-01)

Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension
by: Pertseva N.O., et al.
Published: (2013-06-01)

Dynamics of morphological changes of platelet granules in patients with hypertension and high cardiovascular risk in applying losartan potassium
by: Tverdokhleb I.V., et al.
Published: (2014-06-01)

Quantitative morphological characteristics of intravascular platelet activity in patients with diabetes mellitus type 2 with arterial hypertension under losartan treatment
by: Dzyak G.V., et al.
Published: (2012-01-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Dynamics of erythrocyte surface cellular composition in patients with diabetes mellitus type 2 with arterial hypertension under correction of arterial blood pressure with losartan
by: Dzyak G.V., et al.
Published: (2013-01-01)

Morphological substrate of platelet hemostasis damage in patients with type 2 diabetes mellitus and hypertension
by: Pertseva N.O.
Published: (2015-12-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

Ultrastructural changes of platelet granules in patients with type 2 diabetes mellitus and hypertension in applying of angiotensin II receptor antagonists
by: Pertseva N.O.
Published: (2016-06-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

Managing blood pressure control in Asian patients: safety and efficacy of losartan
by: Cheung TT, et al.
Published: (2014-03-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2011-12-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension
by: N Sh Zagidullin, et al.
Published: (2009-12-01)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
by: F T Ageev, et al.
Published: (2016-12-01)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
by: Ageev F.T., et al.
Published: (2016-12-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

CHANGES IN THE STRUCTURAL CHARACTERISTICS OF PLATELETS AND LEUKOCYTES IN PATIENTS WITH ARTERIAL HYPERTENSION UNDER THE INFLUENCE OF A HYDROGEN SULFIDE DONOR
by: Alexander Kravchuk, et al.
Published: (2020-05-01)

Lercanidipine and Losartan Effects on Blood Pressure and Fibrinolytic Parameters
by: Tsung-Hsien Lin, et al.
Published: (2006-04-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Metabolic and hemostatic parameters in patients with type 2 diabetes and hypothyroidism
Published: (2011-09-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

Efficacy of a fixed-dose combination (amlodipine/losartan) in the treatment of a patient with arterial hypertension, dyslipidemia and obesity
by: V. P. Mikhin
Published: (2020-01-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
by: Gabriel Mulinari-Santos, et al.

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
by: O. A. Osipova, et al.
Published: (2016-01-01)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
by: Ali Akbar Nekooeian, et al.
Published: (2021-05-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

Changes of and genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
by: Hyeryon Lee, et al.
Published: (2019-03-01)